Indie Asset Partners, LLC Gsk PLC Transaction History

Indie Asset Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $4,205 - $4,777	100 Added 1.64%	6,200 $270,000
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $18,103 - $21,483	450 Added 7.96%	6,100 $266,000
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $206,338 - $234,249	5,650 New	5,650 $225,000
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $192,455 - $217,099	-5,050 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$37.87 - $43.58 $191,243 - $220,079	5,050 New	5,050 $207,000
Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $171,668 - $258,164	-5,287 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$42.0 - $48.25 $222,054 - $255,097	5,287 New	5,287 $248,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.